Abels, W. C., Manandhar, T., Kunze-Schumacher, H., Blasczyk, R., & Bade-Döding, C. (2018). The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection. Immunogenetics.

Abels, Wiebke C., Trishna Manandhar, Heike Kunze-Schumacher, Rainer Blasczyk, and Christina Bade-Döding. "The Polymorphism At Residue 156 Determines the HLA-B*35 Restricted Peptide Repertoire During HCMV Infection." Immunogenetics 2018.

Abels, Wiebke C., et al. "The Polymorphism At Residue 156 Determines the HLA-B*35 Restricted Peptide Repertoire During HCMV Infection." Immunogenetics 2018.